Search research articles
Contact Us
Filters
Showing results (141-150 of 858) with videos related to
Page
of 86
Sort By:
Critical Pathways in Cardiology
|
March 11, 2010
Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trials
Simona Mega, Giuseppe Patti, Christopher P Cannon, et al.
European Heart Journal
|
October 18, 2022
Individualized therapy in statin intolerance: the key to success
Maciej Banach, Christopher P Cannon, Francesco Paneni, et al.
European Heart Journal
|
September 7, 2006
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
Shaheeda Ahmed, Christopher P Cannon, Sabina A Murphy, et al.
International Journal of Cardiology
|
April 12, 2005
Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16
Olga S Gurjeva, Gene Bukhman, Sabina Murphy, et al.
Reviews in Cardiovascular Medicine
|
May 25, 2010
Patent foramen ovale. Incidental patent foramen ovale during cardiothoracic surgery: to repair or not to repair?
Quynh A Truong, Ana C Garrido-Castro, Christopher P Cannon
American Heart Journal
|
November 5, 2003
Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic intervention
James L Januzzi, Christopher P Cannon, Pierre Theroux, et al.
American Heart Journal
|
August 1, 2006
Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis
Christopher P Cannon, Sean P Curtis, James A Bolognese, et al.
Journal of the American College of Cardiology
|
July 18, 2018
The Evolving Future of PCSK9 Inhibitors
Robert S Rosenson, Robert A Hegele, Sergio Fazio, et al.
JACC. Heart Failure
|
December 1, 2022
Uptake of Newer Guideline-Directed Therapies in Heart Failure Patients With Diabetes or Chronic Kidney Disease
Mario Enrico Canonico, Judith Hsia, Christopher P Cannon, et al.
Critical Pathways in Cardiology
|
December 20, 2007
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed
Geoffrey C Schreiner, Loren Laine, Sabina A Murphy, et al.
Page
of 86
Search research articles
Search
Showing results (141-150 of 858) with videos related to
Sort By:
Page
of 86
Critical Pathways in Cardiology
|
March 11, 2010
Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trials
Simona Mega, Giuseppe Patti, Christopher P Cannon, et al.
European Heart Journal
|
October 18, 2022
Individualized therapy in statin intolerance: the key to success
Maciej Banach, Christopher P Cannon, Francesco Paneni, et al.
European Heart Journal
|
September 7, 2006
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
Shaheeda Ahmed, Christopher P Cannon, Sabina A Murphy, et al.
International Journal of Cardiology
|
April 12, 2005
Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16
Olga S Gurjeva, Gene Bukhman, Sabina Murphy, et al.
Reviews in Cardiovascular Medicine
|
May 25, 2010
Patent foramen ovale. Incidental patent foramen ovale during cardiothoracic surgery: to repair or not to repair?
Quynh A Truong, Ana C Garrido-Castro, Christopher P Cannon
American Heart Journal
|
November 5, 2003
Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic intervention
James L Januzzi, Christopher P Cannon, Pierre Theroux, et al.
American Heart Journal
|
August 1, 2006
Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis
Christopher P Cannon, Sean P Curtis, James A Bolognese, et al.
Journal of the American College of Cardiology
|
July 18, 2018
The Evolving Future of PCSK9 Inhibitors
Robert S Rosenson, Robert A Hegele, Sergio Fazio, et al.
JACC. Heart Failure
|
December 1, 2022
Uptake of Newer Guideline-Directed Therapies in Heart Failure Patients With Diabetes or Chronic Kidney Disease
Mario Enrico Canonico, Judith Hsia, Christopher P Cannon, et al.
Critical Pathways in Cardiology
|
December 20, 2007
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed
Geoffrey C Schreiner, Loren Laine, Sabina A Murphy, et al.
Page
of 86